FDA Sticks Breakthrough Tag on GlaxoSmithKline's Blood Cancer Drug Post author:Sam Post published:November 1, 2017 Post category:BioPharma GSK2857916 is an anti B-cell maturation agent (BCMA) monoclonal antibody-drug conjugate. Source: BioSpace You Might Also Like Spark's Blindness-Curing Gene Therapy Comes With a $850,000 Price Tag January 2, 2018 New Jersey Implant Maker Braeburn Pharma Yanks Plans for $150 Million IPO February 2, 2017 Why a Celgene-Juno Marriage Makes Perfect Sense January 17, 2018
